Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2014

01.06.2014 | Original Article

Preoperative Clostridium difficile Infection Is Not Associated with an Increased Risk for the Infection in Ileal Pouch Patients

verfasst von: Chao Sun, Peng Du, Xian-rui Wu, Elaine Queener, Bo Shen

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Clostridium difficile infection (CDI) might contribute to a refractory course of pouchitis. However, the association between preoperative CDI and postoperative CDI in ileal pouch patients has not been investigated.

Aim

Our study aimed to evaluate whether preoperative CDI had an impact on the occurrence of postoperative CDI in pouch patients.

Methods

Consecutive eligible ileal pouch patients from February 2005 to December 2012 were identified from the Pouchitis Registry at the Cleveland Clinic. Patients in the registry with known status of CDI of the pouch were surveyed with a structured questionnaire regarding preoperative C. difficile test and its treatment. Medical records were also reviewed. Demographics and clinical characteristics and outcomes were evaluated with univariable and multivariable analyses.

Results

A total of 102 patients with preoperative C. difficile test were identified for this study and 21 patients (20.6 %) tested positive for C. difficile test after colectomy. In logistic regression analysis, male patients were 7.85 (P = 0.003) times more likely to have CDI than women. In addition, preoperative significant comorbidities (P = 0.037) and preoperative use antibiotics for other indications (P = 0.005) were found to be associated with postoperative CDI of the pouch. However, there was no evidence to suggest that the preoperative CDI was associated with the occurrence of postoperative CDI (P = 0.769).

Conclusions

Postoperative CDI occurred frequently in male patients with IPAA. In addition, preoperative comorbidities and antibiotic use were found to be risk factors for CDI of the pouch. However, preoperative CDI did not appear to be associated with an increased risk for postoperative CDI in pouch patients.
Literatur
1.
Zurück zum Zitat Psillos AI, Catanzaro J. Ileal pouch anal anastomosis: an overview of surgery, recovery, and achieving postsurgical continence. Ostomy Wound Manag. 2011;57:22–28. Psillos AI, Catanzaro J. Ileal pouch anal anastomosis: an overview of surgery, recovery, and achieving postsurgical continence. Ostomy Wound Manag. 2011;57:22–28.
2.
Zurück zum Zitat Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20–28.PubMedCrossRef Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20–28.PubMedCrossRef
3.
Zurück zum Zitat Shen B, Remzi FH, Lavery IC, et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol. 2008;6:145–158.PubMedCrossRef Shen B, Remzi FH, Lavery IC, et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol. 2008;6:145–158.PubMedCrossRef
4.
Zurück zum Zitat Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4–7.PubMedCrossRef Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4–7.PubMedCrossRef
5.
Zurück zum Zitat Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–307.PubMedCrossRef Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–307.PubMedCrossRef
6.
Zurück zum Zitat Shen B, Jiang ZD, Fazio VW, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6:782–788.PubMedCrossRef Shen B, Jiang ZD, Fazio VW, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6:782–788.PubMedCrossRef
7.
Zurück zum Zitat Shen B, Remzi FH, Fazio VW. Fulminant Clostridium difficile-associated pouchitis with a fatal outcome. Nat Rev Gastroenterol Hepatol. 2009;6:492–495.PubMedCrossRef Shen B, Remzi FH, Fazio VW. Fulminant Clostridium difficile-associated pouchitis with a fatal outcome. Nat Rev Gastroenterol Hepatol. 2009;6:492–495.PubMedCrossRef
8.
Zurück zum Zitat Li Y, Qian J, Queener E, et al. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis. 2013;19:397–403.PubMedCrossRef Li Y, Qian J, Queener E, et al. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis. 2013;19:397–403.PubMedCrossRef
9.
Zurück zum Zitat Shen B, Remzi FH, Oikonomou IK, et al. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol. 2009;104:639–646.PubMedCrossRef Shen B, Remzi FH, Oikonomou IK, et al. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol. 2009;104:639–646.PubMedCrossRef
10.
Zurück zum Zitat Li Y, Shen B. Evaluating pouch problems. Gastroenterol Clin N Am. 2012;41:355–378.CrossRef Li Y, Shen B. Evaluating pouch problems. Gastroenterol Clin N Am. 2012;41:355–378.CrossRef
11.
Zurück zum Zitat Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345–351.PubMedCrossRef Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345–351.PubMedCrossRef
12.
Zurück zum Zitat Clayton EM, Rea MC, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009;104:1162–1169.PubMedCrossRef Clayton EM, Rea MC, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009;104:1162–1169.PubMedCrossRef
13.
Zurück zum Zitat Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–344.PubMedCrossRef Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–344.PubMedCrossRef
14.
Zurück zum Zitat Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin N Am. 2010;94:135–153.PubMedCrossRef Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin N Am. 2010;94:135–153.PubMedCrossRef
15.
Zurück zum Zitat Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. J Am Med Assoc. 2009;301:954–962.CrossRef Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. J Am Med Assoc. 2009;301:954–962.CrossRef
16.
Zurück zum Zitat Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig Dis. 2009;27:555–559.PubMedCrossRef Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig Dis. 2009;27:555–559.PubMedCrossRef
17.
Zurück zum Zitat Wang Y, Atreja A, Wu X, et al. Similar outcomes of IBD inpatients with Clostridium difficile infection detected by ELISA or PCR assay. Dig Dis Sci. 2013;58:2308–2313.PubMedCrossRef Wang Y, Atreja A, Wu X, et al. Similar outcomes of IBD inpatients with Clostridium difficile infection detected by ELISA or PCR assay. Dig Dis Sci. 2013;58:2308–2313.PubMedCrossRef
18.
Zurück zum Zitat Schneeweiss S, Korzenik J, Solomon DH, et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009;30:253–264.PubMedCrossRef Schneeweiss S, Korzenik J, Solomon DH, et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009;30:253–264.PubMedCrossRef
19.
Zurück zum Zitat Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010;16:4892–4904.PubMedCentralPubMedCrossRef Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010;16:4892–4904.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat van der Kooi TI, Koningstein M, Lindemans A, et al. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol. 2008;57:709–716.PubMedCrossRef van der Kooi TI, Koningstein M, Lindemans A, et al. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol. 2008;57:709–716.PubMedCrossRef
22.
Zurück zum Zitat Kariv R, Navaneethan U, Venkatesh PG, et al. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5:34–40.PubMedCrossRef Kariv R, Navaneethan U, Venkatesh PG, et al. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5:34–40.PubMedCrossRef
23.
Zurück zum Zitat Stevens V, Concannon C, van Wijngaarden E, et al. Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated Clostridium difficile infection (CDI) within a retrospective cohort. BMC Infect Dis. 2013;13:150.PubMedCentralPubMedCrossRef Stevens V, Concannon C, van Wijngaarden E, et al. Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated Clostridium difficile infection (CDI) within a retrospective cohort. BMC Infect Dis. 2013;13:150.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Rodríguez-Pardo D, Almirante B, Bartolomé RM, et al. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol. 2013;51:1465–1473.PubMedCentralPubMedCrossRef Rodríguez-Pardo D, Almirante B, Bartolomé RM, et al. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol. 2013;51:1465–1473.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Krapohl GL, Morris AM, Cai S, et al. Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients. Am J Surg. 2013;205:343–347; discussion 347–348.PubMedCrossRef Krapohl GL, Morris AM, Cai S, et al. Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients. Am J Surg. 2013;205:343–347; discussion 347–348.PubMedCrossRef
26.
Zurück zum Zitat Musher DM, Logan N, Bressler AM, et al. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009;48:e41–e46.PubMedCrossRef Musher DM, Logan N, Bressler AM, et al. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009;48:e41–e46.PubMedCrossRef
27.
Zurück zum Zitat Garey KW, Jiang ZD, Bellard A, et al. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study. J Clin Gastroenterol. 2009;43:91–93.PubMedCrossRef Garey KW, Jiang ZD, Bellard A, et al. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study. J Clin Gastroenterol. 2009;43:91–93.PubMedCrossRef
28.
Zurück zum Zitat Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422–431.PubMedCrossRef Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422–431.PubMedCrossRef
29.
Zurück zum Zitat Nelson RL, Kelsey P, Leeman H, et al. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2011;9:CD004610.PubMed Nelson RL, Kelsey P, Leeman H, et al. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2011;9:CD004610.PubMed
30.
Zurück zum Zitat Drekonja DM, Butler M, MacDonald R, et al. Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med. 2011;155:839–847.PubMedCrossRef Drekonja DM, Butler M, MacDonald R, et al. Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med. 2011;155:839–847.PubMedCrossRef
31.
Zurück zum Zitat Kaneko T, Matsuda R, Taguri M, et al. Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients. Clin Res Hepatol Gastroenterol. 2011;35:315–320.PubMedCrossRef Kaneko T, Matsuda R, Taguri M, et al. Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients. Clin Res Hepatol Gastroenterol. 2011;35:315–320.PubMedCrossRef
Metadaten
Titel
Preoperative Clostridium difficile Infection Is Not Associated with an Increased Risk for the Infection in Ileal Pouch Patients
verfasst von
Chao Sun
Peng Du
Xian-rui Wu
Elaine Queener
Bo Shen
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3047-0

Weitere Artikel der Ausgabe 6/2014

Digestive Diseases and Sciences 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.